Main Content
ALS IS A TOUGH DISEASE. IT CALLS FOR AN ORGANIZED AGGRESSIVE APPROACH. WE START BY CONFIRMING THE DIAGNOSIS AND EXCLUDING ALS MIMICS. IF ALS IS CONFIRMED WE USE THE LATEST DISEASE-MODIFYING THERAPIES TO SLOW PROGRESSION. OUR MULTI-DISCIPLINARY TEAM IDENTIFIES SPECIFIC SYMPTOMS AND PROBLEMS AND PROVIDES A WIDE RANGE OF OPTIONS FOR DEALING WITH THEM. WE ARE ALWAYS ON THE LOOKOUT FOR NEW THERAPIES IN OUR ACTIVE RESEARCH PROGRAM. ALL OF US HERE ARE ENTHUSIASTIC AND HOPEFUL!
ALS IS A TOUGH DISEASE. IT CALLS FOR AN ORGANIZED AGGRESSIVE APPROACH. WE START BY CONFIRMING THE DIAGNOSIS AND EXCLUDING ALS MIMICS. IF ALS IS CONFIRMED WE USE THE LATEST DISEASE-MODIFYING THERAPIES TO SLOW PROGRESSION. OUR MULTI-DISCIPLINARY TEAM IDENTIFIES SPECIFIC SYMPTOMS AND PROBLEMS AND PROVIDES A WIDE RANGE OF OPTIONS FOR DEALING WITH THEM. WE ARE ALWAYS ON THE LOOKOUT FOR NEW THERAPIES IN OUR ACTIVE RESEARCH PROGRAM. ALL OF US HERE ARE ENTHUSIASTIC AND HOPEFUL!
Recent and Upcoming Events
It’s going to be a busy Fall here
In addition to our clinics, research and advocacy programs, we will be attending:
| September 21-24 | AANEM Meeting |
| September 28 | Our team will be speaking at BrainWeek in Las Vegas. You can register for this conference HERE |
| October 8 | The ALSA Florida Chapter’s Help & Hope Symposium |
| October 12 | Duke’s Forever Learning Institute |
| November 1-3 | NEALS Meeting |
| November 7 | ALS NC Chapter’s Caregiver Conference |
| November 22 | Speaking for Argentina MND Association |
| November 23 | Everything ALS |
| December 7 | Duke’s Clinical Neuroscience Grand Rounds |
September 17, 2022
Sola 5K raised over $100,000 for ALS Research!
Thanks to all the sponsors and families who came out and supported this event.
September 12, 2022
New Medscape Program we helped facilitate entitled “The Spectrum of Weakness in ALS
A Look into the Future is now available HERE
September 6, 2022
New CReATe Author Series Podcast just dropped.
This one discusses the recent paper titled “Urinary neopterin: A novel biomarker of disease progression in amyotrophic lateral sclerosis”. You can listen to this and several other podcasts designed to try to make research more understandable for non-scientists here
August 30, 2022
New collaborative study involving Duke and GenieUS finds marker that appears to protect against ALS.
You can read the paper here
